TabletsPrednisoneTherapeutic EquivalencyTablets, Enteric-CoatedAdministration, OralDelayed-Action PreparationsChemistry, PharmaceuticalVincristineCross-Over StudiesExcipientsBiological AvailabilityDrug Administration ScheduleDouble-Blind MethodCyclophosphamideDrug CompoundingTreatment OutcomeGlucocorticoidsTechnology, PharmaceuticalDoxorubicinMethylcelluloseProcarbazineAntineoplastic Combined Chemotherapy ProtocolsPrednisoloneMechlorethaminePowdersAnti-Inflammatory Agents, Non-SteroidalAzathioprineImmunosuppressive AgentsDrug Therapy, CombinationChromatography, High Pressure LiquidDose-Response Relationship, DrugSolubilityMelphalanMitoxantroneHardnessAntibodies, Monoclonal, Murine-DerivedAnti-Inflammatory AgentsBleomycinMethotrexateColor TherapyLubricantsRemission InductionDosage FormsChlorambucilCapsulesLymphoma, Non-HodgkinCyclosporineCellulosePovidoneHodgkin DiseaseLymphoma, Large B-Cell, DiffuseDrug StabilityMycophenolic AcidTime FactorsFollow-Up StudiesHardness TestsAdministration, BuccalVinblastineAsparaginaseAdrenal Cortex HormonesThalidomideMultiple MyelomaKidney TransplantationRecurrenceEtoposideClinical Trials as TopicSurvival AnalysisGraft RejectionDisease-Free SurvivalTacrolimusCompressive StrengthCarboxymethylcellulose SodiumMethylprednisoloneSurvival RateSuspensionsProspective StudiesCombined Modality TherapyNephrotic SyndromePolymethacrylic Acids